Skip to Content

E617 20 (Opana ER 20 mg)

Generic Name: oxymorphone

Pill with imprint E617 20 is Green, Eight-sided and has been identified as Opana ER 20 mg. It is supplied by Endo Pharmaceuticals Inc..

Opana ER is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Opana ER 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for E617 20

Opana ER 20 mg E617 20

Opana ER

Generic Name
oxymorphone
Imprint
E617 20
Strength
20 mg
Color
Green
Size
8.00 mm
Shape
Eight-sided
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Endo Pharmaceuticals Inc.
National Drug Code (NDC)
63481-0617
Inactive Ingredients
hypromelloses, methylparaben, sodium stearyl fumarate, titanium dioxide, triacetin, polyethylene glycol, polysorbate 80, FD&C Blue No. 1, FD&C Yellow No. 6, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Submitted by: Drugs.com

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.